Business · 09/07/2007

FDA to Host Public Meeting on Proposed Rule to Remove Essential-Use Designations for Certain Oral Pressurized Metered-Dose Inhalers

The Food and Drug Administration (FDA) is hosting a public meeting to gather public comments on a proposed rule that would eliminate essential-use designations for certain oral pressurized metered-dose inhalers (MDIs) containing specific medications, including Flonase and ProAir. The meeting aims to consider public input in finalizing the rule.